No Data
Guan Hao Biology: 2024 Annual Report
Guan Hao Biology: 2024 Annual Report Summary
Guan Hao Biology: Report for the first quarter of 2025
Guanhao Biotech (300238.SZ) announced its performance for 2024, with a net income of 27.4169 million yuan, a year-on-year decrease of 11.57%.
Guanhao Biotech (300238.SZ) released the annual report for 2024, with revenue for the year 2024 amounting to 3....
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Do Its Financials Have Any Role To Play In Driving Guanhao Biotech Co.,Ltd.'s (SZSE:300238) Stock Up Recently?
Guanhao BiotechLtd (SZSE:300238) Delivers Shareholders Notable 7.1% CAGR Over 5 Years, Surging 12% in the Last Week Alone
